Sol SpA operates in the Home health care services sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sol SpA with three other
health care providers in Europe:
Ambea Ab (Publ)
sales of 11.04 billion Swedish Kronor [US$1.30 billion]
of which 33%
(7.47 billion Swedish Kronor [US$879.02 million]
of which 37%
was Personal Assistance), and
Aevis Victoria SA
based in SWITZERLAND
(844.85 million Swiss Francs [US$930.44 million]
of which 63%
Sol SpA reported sales of 904.31 million Euro (US$1.08 billion)
December of 2019.
increase of 8.5%
versus 2018, when the company's sales were 833.51 million Euro.
Sales at Sol SpA have increased during each of the previous five years
(and since 2014, sales have increased a total of 42%).
Sales of Homecare saw an increase
14.3% in 2019, from
431.33 million Euro to 492.89 million Euro.